yh32367
mAbexperimentalBi-specific
Clinical trial activity
1 trials · 15 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 26, 2022 (NCT05523947)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
TNFRSF9 antagonist
- Receptor protein-tyrosine kinase erbB-2ANTAGONIST
ERBB2 antagonist
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05523947 | Phase 1/Phase 2 (Phase 2) | Aug 26, 2022 | Ajou University, Austin Health, Catholic University of Korea, Cha Medical University, Chonbuk National University, Gyeongsang University, Harvard University, Korea University, Seoul National University, Southern Oncology Clinical Research Unit, Sungkyunkwan University, University of Ulsan, Vanderbilt University, Yonsei University, Yuhan Pharmaceutical Company |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ajou University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Austin Health | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Cha Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Chonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Gyeongsang University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Southern Oncology Clinical Research Unit | For profit | 1 | 0 | 1 | 2022 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Yuhan Pharmaceutical Company | For profit | 1 | 1 | 1 | 2022 |
15 organizations
Page 1 / 1